AMCP signed on to a joint letter with other Medicare program stakeholders to HHS Secretary Azar detailing concerns with a recent Executive Order that would make changes to the anti-kickback safe harbor for manufacturer rebates and increase costs for patients.
AMCP joined with other national pharmacy stakeholders to thank HHS Secretary Azar for the agency's authorization of pharmacist administration of children's vaccines.
The leaders of 12 U.S. pharmacy organizations today issued the following statement celebrating the U.S. Department of Human Services order this week that expands the role of pharmacists in providing vaccines to children.
On August 4, 2020, CMS issued a request for information on implementation of requirements for electronic prescribing of controlled substances in Medicare Part D. Please send any feedback to advocacy@amcp.org by September 25.
Sponsored webinar that discussed a new strategy for avoiding waste and improving response for highest cost therapies used in managing rheumatoid arthritis.
Sponsored webinar that reviewed the recommended asthma tools for assessment and management, as well as pharmacotherapy considerations to improve risk management and control.